Andover, UK; parent of Shire companies; acquired Roberts Pharmaceutical Corp. in Dec, 1999, and BioChem Pharma in Dec. 2000; divested its vaccine business to ID Biomedical in April 2004; Shire acquired Transkaryotic Therapies, Inc. in April 2005 for ~$1.6 billion
